Medical/Pharmaceuticals
Duality Biologics and GSK Enter Exclusive Option Agreement for a Novel Antibody-drug Conjugate (DB-1324)
PRINCETON, N.J., SHANGHAI and SUZHOU, China, Dec. 3, 2024 /PRNewswire/ -- Duality Biologics ("DualityBio"), a clinical-stage biotech company focusing on the discovery and development of next-generation antibody-drug conjugate (ADC) therapeutics, today announced that it has entered into an exclusi...
2024-12-04 08:30
1149
Innovent and HUTCHMED Jointly Announce NMPA Conditional Approval for TYVYT® (Sintilimab Injection) in Combination with ELUNATE® (Fruquintinib) for the Treatment of Advanced Endometrial Cancer
SAN FRANCISCO, U.S. and SUZHOU, China, Dec. 4, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoi...
2024-12-04 08:00
2073
VivaVision Announces Positive Topline Results from Phase 2 Trial of VVN461 for Post-Operative Inflammation Following Cataract Surgery
* VVN461, a non-steroidal dual JAK1/TYK2 immunomodulator, achieves primary endpoint, demonstrating statistical and clinical efficacy compared to vehicle in treating post-operative inflammation following cataract surgery * Statistically and clinically meaningful reductions in inflammation and ...
2024-12-04 00:00
1657
Biogénesis Bagó opens offices in Vietnam, strengthening its presence in Asia
After years of commitment to animal health in the Asian market providing high-quality biotechnological solutions, this significant milestone further strengthens the company's long-term expansion strategy in the region. This is also reinforced by the recent launch of the FMD vaccine, Bioaftogen, i...
2024-12-03 23:34
1667
ShiraTronics Initiates IDE Pivotal Study of Implantable Neuromodulation Therapy for Chronic Migraine
First Implants of Innovative Device Completed in the United States and Australia MINNEAPOLIS, Dec. 3, 2024 /PRNewswire/ -- ShiraTronics, a clinical-stage innovator in neuromodulation technology, today announced the initiation of its U.S. Food and Drug Administration (FDA)-approved Investigation D...
2024-12-03 23:07
1203
Turn Biotechnologies Announces Landmark Study to Assess Effectiveness of ERA™ Therapy in Restoring Bone Marrow
Researchers from Children's Hospital of Philadelphia (CHOP) seek to expand treatment access for patients MOUNTAIN VIEW, Calif., Dec. 3, 2024 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation and restoration company developing novel mRNA medicines for untreatable, age-related conditions, ...
2024-12-03 22:00
1274
Terumo Interventional Systems Announces Launch of Its R2P NaviCross Peripheral Support Catheter
– Provides interventionalists with optimal product choices for more complex radial-to-peripheral procedures– SOMERSET, N.J., Dec. 3, 2024 /PRNewswire/ -- Terumo Interventional Systems (TIS), a division of Terumo Corporation, is pleased to announce the launch and commercial availability of its R2...
2024-12-03 21:00
885
A New Hope for Atrial Fibrillation Patients with Breakthrough Catheter Technology
BTL, a leader in medical innovation, is proud to announce a major milestone: the successful treatment of the first patients suffering from atrial fibrillation (AF) in a groundbreaking study using a next-generation catheter designed to improve the way AF is treated. PRAGUE, Dec. 3, 2024 /PRNewswi...
2024-12-03 21:00
1155
Samsung Biologics hosts ESG event with suppliers to strengthen decarbonization efforts
INCHEON, South Korea, Dec. 3, 2024 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today hosted its second Supplier ESG Day to share insights on sustainable management and encourage ESGactions among suppliers. Second of i...
2024-12-03 20:00
1236
Fangzhou Inc. Announces Inclusion of Its Shares in Hang Seng Hong Kong-Listed Biotech Index
HONG KONG, Dec. 3, 2024 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, announced today that the Company's Ordinary Shares, which trade on The Stock Exchange of Hong Kong Limited ("HKEX"), will be included in the Hang Seng Hong Ko...
2024-12-03 18:47
1167
InventisBio Announces Positive Phase 2 Study Results for D-2570 (TYK2 Inhibitor) in Patients with Moderate to Severe Plaque Psoriasis
– D-2570 demonstrates robust efficacy and favorable safety profile, achieving skin clearance comparable to leading biologics – SHANGHAI, Dec. 3, 2024 /PRNewswire/ -- InventisBio Co., Ltd. today announced promising results from a Phase 2 clinical trial of D-2570, an oral selective inhibitor of th...
2024-12-03 17:44
1225
AC Health makes critical HIV care more accessible to Filipinos with USAID support
MANILA, Philippines, Dec. 3, 2024 /PRNewswire/ -- Ayala Healthcare Holdings, Inc. (AC Health), in partnership with the U.S. Agency for International Development (USAID), is leading the private sector's efforts to fight the HIV epidemic inthe Philippines by improving access to stigma-free care and...
2024-12-03 16:11
4527
ZEISS Debuts MYO 200 Biometer for Myopia Management in Hong Kong, Built on ZEISS "Gold Standard" Technology to Safeguard the Visual Health of Children and Adolescents
HONG KONG, Dec. 3, 2024 /PRNewswire/ -- Global optical technology leader ZEISS debuted the ZEISS MYO 200 Biometer for Myopia Management inHong Kong on November 28th, to provide more precise myopia control and improved visual health for children and adolescents. Specifically tailored for children ...
2024-12-03 15:13
2059
Pfizer Receives Authorization from Health Authority for Its 20-valent Pneumococcal Conjugate Vaccine for Infants and Children
* In Hong Kong, the 20-valent Pneumococcal Conjugate Vaccine (PCV20) that offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine – helping to fight against 20 serotypesleading to most of the invasive pneumococcal diseases and pneumonia[i],[ii] – is now approved fo...
2024-12-03 15:08
1794
HKBU scientist's Automated Multiplex Diagnostics System recommended by WHO as an innovative health technology for low-resource contexts
HONG KONG, Dec. 3, 2024 /PRNewswire/ -- The Automated Multiplex Diagnostics System developed by Professor Terence Lau, Interim Chief Innovation Officer of Hong KongBaptist University (HKBU), has been recommended in the 2024 Compendium of Innovative Health Technologies for Low-resource Settings pu...
2024-12-03 15:03
1195
Beijing Review: Love Without Barriers
BEIJING, Dec. 3, 2024 /PRNewswire/ -- Meide Yanyuan, a courtyard in Beijing's Changping District, is a studio for those seeking prosthetics and orthotics. Here, under the care ofGeorg Hoffmann-Kuhnt, a German prosthetist and orthotist, bodies and lives are given new strength. Many of its visitors...
2024-12-03 14:27
952
Fosun's Rural Doctors Program Recognized in UNGC's "20 Cases of Private Sector's Sustainable Development in China for 20 Years" Report
HONG KONG, Dec. 3, 2024 /PRNewswire/ -- This year marks the 20th anniversary of the United Nations Global Compact ("UNGC")'s introduction of Environmental, Social, and Governance (ESG) concept and principles. On29 November 2024, the UNGC held a launch event for the "20 Cases of Private Sector's S...
2024-12-03 11:47
1683
Neusoft Medical Systems Showcases AI-powered Medical Imaging Solutions at RSNA 2024
CHICAGO, Dec. 3, 2024 /PRNewswire/ -- Neusoft Medical Systems Co., Ltd. ("Neusoft Medical Systems"), a global leader in medical imaging solutions and services, is proud to announce its participation in the Radiological Society of North America (RSNA) 2024 Annual Meeting, taking place in Chicago fr...
2024-12-03 09:50
1627
ReCerf® Hip Resurfacing Arthroplasty, from MatOrtho® Becomes the World's First All-Ceramic Hip Resurfacing Approved by a Regulatory Authority
Groundbreaking Innovation Receives TGA Approval in Australia LEATHERHEAD, England, Dec. 3, 2024 /PRNewswire/ -- MatOrtho, the UK-based global innovator of hip and knee replacement devices, today announced that the ReCerf® Hip Resurfacing Arthroplasty has become the world's first all-ceramic hip ...
2024-12-03 00:08
1528
2024 Medtec Attracts Over 80,000 Industry Attendees, Helping China's Medical Device Sector Step into a New Era of Quality Development
SHANGHAI, Dec. 2, 2024 /PRNewswire/ -- The 2024 Medtec and the 18th International Medical Device Design & Manufacturing Technology Exhibition (hereinafter referred to as 2024 Medtec), organized by Informa Markets, was successfully held at the Shanghai World Expo Exhibition and Convention Center ...
2024-12-02 23:00
1046
Week's Top Stories
Most Reposted
COCONEXT 2024 - FIRST EVER INTERNATIONAL COCONUT CONFERENCE HOLD IN VIETNAM
[Picked up by 298 media titles]
2024-12-31 14:18
Dahua Technology Obtains ISO 37301 Compliance Management System Certification
[Picked up by 281 media titles]
2024-12-30 15:33
Interest-Driven Consumption Sparks ¥ 500B ACG Goods Market, MINISO Rides the Wave
[Picked up by 277 media titles]
2025-01-03 19:33
Russell Reynolds Associates Appoints Euan Kenworthy as Singapore Country Manager
[Picked up by 276 media titles]
2025-01-02 08:16
CKGSB Professor Mei Jianping Launches Global Indices Tracking Impressionist, Contemporary, and Chinese Art Markets
[Picked up by 258 media titles]
2024-12-31 22:30Most Read
Dahua Technology Obtains ISO 37301 Compliance Management System Certification
2024-12-30 15:33
8705
COCONEXT 2024 - FIRST EVER INTERNATIONAL COCONUT CONFERENCE HOLD IN VIETNAM
2024-12-31 14:18
8703